
Evolent Health, Inc.
Evolent Health, Inc.(EVH)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
evh · 股价预测 · 29 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 29 位华尔街分析师
Buy
29 位分析师
共识
评级分布
12 个月目标价
High
$10.00
Consensus
$6.38
+38.8% upside
Low
$3.50
Median: $6 · Last Close: $4.59
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$6.38
38.8% upside
High Target
$10
117.6%
Low Target
$3.5
-23.8%
Current Price
$4.59
as of today
Based on analyst price targets, the EVH stock price prediction for the next 12 months ranges from $3.5 to $10. The consensus EVH price forecast of $6.38 implies 38.8% upside from the current price of $4.59.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.73 | ↑ 2.86% |
1-day model range: $4.68–$4.77. Peak: $4.77 (+2.86%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -50.0% |
| 2028 | $2 | -63.8% |
| 2029 | $1 | -69.2% |
| 2030 | $1 | -71.8% |
| 2031 | — | -73.1% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · EVH · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Citigroup | Maintains | Buy→Buy |
| 2026-05-12 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-05-07 | Needham | Maintains | Buy→Buy |
| 2026-03-02 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-02-26 | UBS | Maintains | Buy→Buy |
| 2026-02-26 | Truist Securities | Maintains | Buy→Buy |
| 2026-02-26 | Citigroup | Maintains | Buy→Buy |
| 2026-02-25 | BTIG | Maintains | Buy→Buy |
| 2026-02-25 | Needham | Maintains | Buy→Buy |
| 2026-02-25 | RBC Capital | Maintains | Sector Perform→Sector Perform |
Wall Street analysts have recently issued updated ratings on Evolent Health, Inc. (EVH) stock. Of the recent 144 rating actions, 2 were upgrades and 6 were downgrades. 29 analysts currently cover EVH.
分析师推荐趋势
EVH analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 3 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$2.5B
↓ 25.3% YoY
Revenue Next Year
$2.9B
↑ 17.7% YoY
EPS This Year
$0.17
EPS Next Year
$0.38
↑ 121.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast EVH EPS of $0.17 for the current fiscal year, based on estimates from 7 analysts. The EVH revenue forecast is $2.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
EVH 股价预测由两类独立数据源支撑:来自 29 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。EVH 的共识目标价为 $6.38(+38.8% 上行空间),分析师共识为 Buy。
EVH 的短期预测(明日)为 $4.73(+2.86%)。 EVH 对 2027 年的股价预测均值为 $2。 EVH 对 2030 年的预测区间为 $1–$1。
Evolent Health, Inc. 在 NYSE 上市,代码 EVH。EVH 在 2027 年的整体展望偏积极,在覆盖分析师中约 79% 对应 Buy 共识。
常见问题
EVH 预测 · 8 个问题根据 29 位华尔街分析师,EVH 的 12 个月平均目标价为 $6.38,最高 $10.00、最低 $3.50。若有图表,中位目标价可在上方查看。相对当前价 $4.59,隐含约 +38.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.